Änderungen

279 Bytes hinzugefügt ,  13:13, 31. Okt. 2009
Zeile 66: Zeile 66:  
*Explorative Phase II Clinical Trial on the Efficacy and Tolerability of Regividerm in Atopic Dermatitis, randomised, double-blind and placebo-controlled monocentre study with n=20 patients in intraindividual left/right side comparison. 2001, Universität Münster, Klinik Hornheide (Dr. Hans-Joachim Schulze)
 
*Explorative Phase II Clinical Trial on the Efficacy and Tolerability of Regividerm in Atopic Dermatitis, randomised, double-blind and placebo-controlled monocentre study with n=20 patients in intraindividual left/right side comparison. 2001, Universität Münster, Klinik Hornheide (Dr. Hans-Joachim Schulze)
 
*Regividerm in Psoriasis, randomised, double-blind and placebo-controlled monocentre study with n=21 patients in intraindividual left/right side comparison. 2002, Universität Münster Klink Hornheide (Dr. Hans-Joachim Schulze)
 
*Regividerm in Psoriasis, randomised, double-blind and placebo-controlled monocentre study with n=21 patients in intraindividual left/right side comparison. 2002, Universität Münster Klink Hornheide (Dr. Hans-Joachim Schulze)
 +
 +
===Abgebrochene Studien===
 +
*Abgebrochene Studie ''Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis'' April 2007. Study ID Number: IRB00001369, ClinicalTrials.gov Identifier: NCT00465699 [http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00465699]
    
===Nebenwirkungen===
 
===Nebenwirkungen===
23.054

Bearbeitungen